We compared an antigen capture assay (Abbott Laboratories, North Chicago, Ili.) with a reverse transcriptase assay to identify and quantify human immunodeficiency virus (HIV) in culture. In direct comparisons of serial dilutions of Iymphadenopathy-associated virus type 1, the antigen assay was 100-fold more sensitive than the reverse transcriptase assay in detecting the virus. The antigen assay reacted strongly with 60 different HIV isolates but did not cross-react with human T-cell lymphotropic virus type I, human T-cell lymphotropic virus type Il, cytomegalovirus, varicella-zoster virus, herpes simplex virus type 1, Epstein-Barr virus, adenovirus type 5, or poliovirus type 1 or with extracts from four different control human cell lines and eight different phytohemagglutinin-stimulated normal human lymphocytes. Peripheral blood lymphocyte samples from 50 individuals were evaluated by both the antigen assay and the reverse transcriptase assay. The cells from the 34 seropositive individuals were all positive by the antigen assay (range, 3 to 9 days; average time, 5.9 days) and the reverse transcriptase assay (range, 7 to 16 days; average time, 9.6 days). Cells from the 16 seronegative individuals were negative by both assays. These results indicate that the antigen assay is an important addition to the monitoring of HIV production in the lymphocytes of infected patients.
Acquired immunodeficiency syndrome (AIDS) is caused by a human retrovirus (human T-cell lymphotropic virus type III, lymphadenopathy-associated virus type 1 [LAV-1], AIDS-related retrovirus type 2) that is now called human immunodeficiency virus (HIV)
. Although serologic assays are capable of identifying prior exposure to HIV or HIV antigens, they do not necessarily indicate whether an individual is carrying the virus. This requires the isolation of the virus from HIV-seropositive individuals. Isolation of HIV involves prolonged cocultivation of lymphocytes from the individual being tested with phytohemagglutinin (PHA)-stimulated lymphoblasts from an uninfected donor or with a susceptible uninfected indicator cell line (4) . Virus production is then monitored by testing the culture fluids for the presence of the HIV enzyme reverse transcriptase (RT) (9) . The use of RT as a marker for virus production suffers from the following: (i) it is difficult to perform RT assays (RTAs); (ii) it is nonspecific as a marker for HIV and is not able to distinguish among retroviruses; i.e., all retroviruses possess RT, and therefore, further confirmation is required; and (iii) it requires at least 1 to 3 weeks of cocultivation of lymphocytes from the patient with PHA-stimulated lymphoblasts for the detection of virus production. In addition to RT, other HIV proteins represent markers that can be used to monitor specifically for the presence of HIV. The objective of this study was to compare a sensitive and quantitative immunologic assay for the HIV-specific protein p24 with RTA to detect and quantify HIV in culture.
MATERIALS AND METHODS
Virus isolation. Previously described virus isolation techniques were used (4). Lymphocytes were thawed and then cocultivated with 3-day-old PHA-stimulated normal human lymphocytes in RPMI 1640 medium containing 5% interleukin-2. Normal human lymphocytes and medium were * Corresponding author. added every 4 to 5 days. The cultures were monitored for virus replication by RTA and by the antigen assay (AgA; Abbott Laboratories, North Chicago, Ill.).
RTA micromethod. In the RTA micromethod (4), 20-,ul samples of solubilized virus were transferred into the wells of a 96-well flat-bottomed microtiter plate. Subsequently, 180 ,ul of the reaction mixture was added to each well. The plates were covered and incubated at 37°C for 2 h. tRNA (10 ,u1 ) was added to each well, and then 100 ,ul of cold 10% trichloroacetic acid was added. The plates were harvested with a semiautomatic cell harvester (Skatron). After the glass fiber filter sheet was dried, the disks containing the precipitable DNA were placed into scintillation vials. Scintillation fluid (2 ml) was added to each vial. The vials were counted in a beta scintillation counter. The results are presented as counts per minute.
AgA. Cell culture supernatant samples were clarified (by centrifugation at 1,000 x g for 10 min) and then assayed for HIV antigen in a solid-phase, sandwich-type enzyme immunoassay by using an unmodified human T-cell lymphotropic virus type III antigen enzyme immunoassay test kit (Abbott) (5) . In this test polyclonal antibodies to HIV were used as capture and probe antibodies, and a labeled second antibody conjugate was used to identify the presence of HIV antigen in the supernatant. The A492 was read with a quantum dual-wavelength spectrophotometer. All samples that were positive at one time point were retested, and the repeatedly reactive samples were subsequently confirmed by an inhibition test (termed neutralization test in the Abbott kit). Repeatedly reactive specimens neutralized by this procedure were considered positive for HIV antigen(s).
RESULTS AND DISCUSSION
To compare directly the sensitivities of AgA and RTA, a purified cell-free preparation of LAV-1 was serially 10 Peripheral blood lymphocytes from 50 high-risk patients were cocultured with peripheral blood lymphocytes from normal donors, and supernatants from each coculture were evaluated by both RTA and AgA. Fractions were removed every day for assay. This was done over a 24-day period. RTA was performed on the supernatant concentrates, whereas AgA was performed on the supernatant directly. Efforts were made to enhance antigen detection by highspeed centrifugation (150,000 x g for 30 min) or by polyethylene glycol precipitation to concentrate HIV antigen. Highspeed centrifugation worked well, yielding a 7-fold increase in antigen titer after the solution containing virus was concentrated 10-fold. However, high-speed centrifugation to concentrate the virus was not necessary for antigen detection. Concentration of the virus with polyethylene glycol yielded inconsistent results and was not pursued further. The cells from the 34 individuals who tested positive for HIV antibodies by the enzyme-linked immunosorbent assay and Western blot (immunoblot) tests and from whom HIV had been previously isolated were all positive by both AgA and RTA. Cells from the 16 randomly selected individuals who tested negative for HIV antibodies by the enzyme-linked immunosorbent assay were all negative by both AgA and RTA.
The 34 seropositive samples were subsequently compared to determine the number of days originally required to detect virus in culture by both RTA and AgA (Fig. 1) . RT activity originally appeared in all 34 culture supernatants from 7 to 16 days after culture initiation. The average time for detection of HIV by RTA was 9.6 days. In contrast, p24, which was originally detectable by AgA, appeared in all 34 culture supernatants from 3 to 9 days after culture initiation, with an VOL. 25, 1987 2346 FEORINO ET AL. average detection time of 5.9 days. There was essentially a direct correlation within samples between days to antigen positivity versus days to RT positivity.
In summary, we have presented evidence that the AgA for detection of p24 of human T-cell lymphotropic virus type III is highly sensitive and specific for HIV and is superior to RTA for monitoring virus production in culture. In addition, AgA requires considerably less time (approximately 4 days) for a positive result. AgA is highly reactive against a broad array of HIV isolates, presumably because the p24 core antigen, which appears to be a highly conserved viral protein (1, 10) , is detected by the assay.
The combination of an AgA for HIV proteins (an assay specific for HIV) with RTA (a nonspecific retrovirus assay) could be used to detect new human retroviruses other than HIV. The result would appear as a negative AgA with a positive RTA. In studies in which cells from patients are used, AgA will be an important addition for monitoring the production of HIV in culture.
